-
Endocrine Adverse Events Related to Immune-Oncology Agents
Learn more about the endocrine-related adverse events associated with the use of immune-oncology agents and how these toxicities should be managed.
May 08, 2020
-
Toxicity of Tumor Immune Checkpoint Inhibitors
Are you aware of the potential adverse events associated with immune checkpoint inhibitors? Find out how to identify and manage these toxic effects.
March 03, 2020
-
Society for Translational Medicine Consensus on Postoperative Management of EGFR-Mutant Lung Cancer (2019 Edition)
Consensus-based recommendations from the Society for Translational Medicine addresses the management of EGFR-mutated lung cancer.
February 03, 2020
-
Is Lowering the PD-L1 Threshold for First-Line Pembrolizumab Monotherapy a Good Idea?
What is the best treatment option for patients with advanced NSCLC and PD-L1 of 1-49% on tumor cells?
January 02, 2020
-
Current Perspectives on Statins as Potential Anti-Cancer Therapeutics
Which molecular mechanisms may drive the anticancer effects of statins?
December 03, 2019
-
Influence and Mechanism of Lung Cavitation Development on Antiangiogenic Therapy
Is development of lung cavitation following apatinib therapy for lung cancer associated with better outcomes?
November 06, 2019
-
Treatment Modes for EGFR Mutations in Patients With Brain Metastases From Non-Small Cell Lung Cancer
Medical oncologists and radiation oncologists often disagree about management of brain metastases associated with EGFR+ NSCLC. These authors think "interdisciplinary collaboration" is needed.
October 22, 2019
-
Prognostic Role of Pretreatment Neutrophil-to-Lymphocyte Ratio in Non-Small Cell Lung Cancer Patients Treated With Systemic Therapy
Is an elevated neutrophil-to-lymphocyte ratio prior to receiving chemotherapy, immunotherapy, or targeted therapy associated with inferior survival in patients with NSCLC ?
September 27, 2019
-
Molecular Testing Strategies in Non-Small Cell Lung Cancer
These 'real world' tactics for molecular testing in patients with a new diagnosis of advanced NSCLC will help clinicians determine optimal first-line targeted therapy.
August 29, 2019
-
TNM Stages Inversely Correlate With The Age at Diagnosis in ALK-Positive Lung Cancer
Younger adults are more likely to be diagnosed with T3/4 stage ALK-positive lung cancer than older adults.
July 29, 2019
-
Lung Cancer Screening and Shared Decision Making in Cancer Survivors
Little is known about the effectiveness of lung cancer screening in cancer survivors, a group with very diverse characteristics. How should clinicians frame shared decision making discussions?
June 28, 2019
-
Combining Stereotactic Body Radiation Therapy With Immunotherapy
Learn about ongoing clinical trials and the potential for clinical synergy between radiation and immunotherapy.
May 29, 2019
-
Empiric Radiotherapy for Lung Cancer Collaborative Group Multiinstitutional Evidence-Based Guidelines for the Use of Empiric Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer Without Pathologic Confirmation
What is the overall efficacy of stereotactic body radiation therapy for patients with early stage NSCLC when biopsy confirmation is too high-risk?
April 29, 2019
-
Predictive Markers for Anti-PD-1/PD-L1 Therapy in Non-Small Cell Lung Cancer
What is the current outlook for using predictive markers to guide treatment for patients with NSCLC? What challenges face laboratories implementing these tests?
March 29, 2019
-
Measuring Tumor Mutation Burden in Non-Small Cell Lung Cancer
Tumor mutation burden may be a promising tool to guide immunotherapy, yet many questions need to be answered before adoption into clinical practice.
February 28, 2019
-
Combined Modality Treatment in Mesothelioma
Is combined modality treatment using surgery, radiotherapy and/or chemotherapy improving outcomes in malignant mesothelioma?
January 30, 2019
-
Current Chemotherapy Strategies in Malignant Pleural Mesothelioma
Is immunotherapy beneficial in patients with progressive malignant pleural mesothelioma after initial platinum-based chemotherapy?
December 31, 2018
-
Inherited Lung Cancer Syndromes Targeting Never Smokers
Which germline mutations are associated with inherited lung cancer syndromes in never smokers?
November 30, 2018
-
Ground-Glass Nodules of the Lung in Never-Smokers and Smokers
How long should ground glass nodules of the lung be monitored and what are predictors of their growth?
October 31, 2018
-
Appropriate Screening Intervals in Low-Dose CT Lung Cancer Screening
In which patients may a prolonged lung cancer screening interval be used?
September 03, 2018
